RayzeBio, Inc. Quarterly Liabilities and Equity in USD from Q4 2022 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: RayzeBio, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2022 to Q3 2023.
RayzeBio, Inc. Liabilities and Equity for the quarter ending September 30, 2023 was $604M.

Liabilities and Equity, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$604M			Sep 30, 2023	10-Q	2023-11-13
Q4 2022	$325M			Dec 31, 2022	10-Q	2023-11-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.